Biogen Inc. 8-K Filing: Key Update on October 14, 2025

Based on the extracted section of the financial report (an 8-K filing for Biogen Inc.), here are the key pieces of information:

1. Company Information:

• Name: Biogen Inc.
• Location: 225 Binney Street, Cambridge, MA 02142
• Phone: 617-679-2000
• CIK (Central Index Key): 0000875045
• SEC File Number: 0-19311
• IRS Employer Identification Number: 33-0112644

2. Filing Details:

• Filing Type: 8-K (Current Report)
• Filing Date: October 14, 2025

3. Securities Information:

• Common Stock Par Value: $0.0005
• Ticker Symbol: BIIB
• Exchange: NASDAQ

4. Period of Report:

• Report Date: The report covers a single day, October 14, 2025.

Insights:

• The 8-K filing indicates that this document is intended to report significant events or corporate changes that may be of interest to shareholders and the SEC.
• The timing of the report (a single day) suggests it may contain information about a specific event that occurred on that date.
• Biogen, being a prominent biotechnology company, often has significant news that could affect stock performance, making this filing particularly important for investors and analysts.
• The report confirms the company's compliance with SEC regulations, as evidenced by the structured XML format used for the filing.

Conclusion:

This filing serves as a communication tool for Biogen to relay important information to investors and regulators, and it is essential for stakeholders to review the full 8-K document for detailed disclosures regarding any events that occurred on the filing date.